Advanced Cell Technology Announces Investor Conference Call to Be Held Friday January 19 to Discuss Key Events and Progress in Stem Cell-Based Therapeutic Programs.

CEO William Caldwell to Review Impact of Federal and State Government Efforts to Spur Development of Human Embryonic Stem Cell Industry

ALAMEDA, Calif. -- Advanced Cell Technology, Inc. (OTCBB:ACTC), applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative medicine, will host an investor conference call on Friday, January 19, at 12 noon Eastern, to discuss recent progress and events with respect to the Company's initiatives to develop stem cell-based therapies for a range of diseases and conditions.

During the conference call, William M. Caldwell, IV, Chairman and Chief Executive Officer of Advanced Cell, will provide an overview of Company activities and news, and will address investor questions. Topics he will cover include the Company's recently announced federal research grant from the National Institutes of Health.

Mr. Caldwell will also comment on the impact of the current political climate on the advancement of stem cell based science and technologies. Some states, including California and New Jersey, have enacted legislation to foster stem cell science. Additionally, the newly elected governor of New York State, Eliot Spitzer, recently advocated passage of a $2 billion 10-year bond initiative for research and development, at least half of which would be earmarked for stem cell research.

Interested investors within the United States can access the conference call by calling [phone]; when prompted tell the operator you would like to connect to the 'Advanced Cell Technology' conference call. International callers can dial [phone]. An online audio web simulcast of the call will also be accessible at http://www.trilogy-capital.com/tcp/advanced_cell.

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts.

For more information, please visit: www.advancedcell.com. For investor-specific information and resources, visit http://www.trilogy-capital.com/tcp/advanced_cell. To read or download Advanced Cell's Investor Fact Sheet, please visit http://www.trilogy-capital.com/tcp/advanced_cell/factsheet.html. To view recent stock quotes and news, visit http://www.trilogy-capital.com/tcp/advanced_cell/quote.html.

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended September 30, 2006.

Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.